NCT07246863
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT07246863
Title Trial Investigating Visugromab and Nivolumab With or Without Docetaxel in 2L Treatment of Participants With Metastatic NSCLC
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors CatalYm GmbH
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | ITA | ESP | DEU | CHE

Facility Status City State Zip Country Details
University of Alabama at Birmingham (O'Neal Comprehensive Cancer Center) NOT_YET_RECRUITING Birmingham Alabama 35294-3300 United States Details
USC Norris Comprehensive Cancer Center RECRUITING Los Angeles California 90033 United States Details
Duke University Medical Center NOT_YET_RECRUITING Durham North Carolina 27710 United States Details
Hospital Esslingen GmbH RECRUITING Esslingen am Neckar Baden-Wurttemberg 73730 Germany Details
Evangelical Hospital Bethel, Clinic for Internal Medicine, Hematology/Oncology, Palliative Medicine Johannesstift RECRUITING Bielefeld North Rhine-Westphalia 33611 Germany Details
Clinics Essen-Mitte RECRUITING Essen North Rhine-Westphalia 45136 Germany Details
Institute of Romagna for Cancer Research "Dino Amadori" - IRCCS IRST RECRUITING Forlì Emilia-Romagna 47014 Italy Details
University Hospital of Jaen RECRUITING Jaén Andalusia 23007 Spain Details
Regional University Hospital of Malaga RECRUITING Málaga Andalusia 29010 Spain Details
University Hospital 12 de Octubre RECRUITING Madrid Madrid 28041 Spain Details
University Hospital Lucus Augusti (HULA) RECRUITING Lugo 27003 Spain Details
University Hospital Basel RECRUITING Basel 4031 Switzerland Details
Cantonal Hospital Saint Gallen, Clinic of Oncology and Hematology RECRUITING Sankt Gallen CH-9007 Switzerland Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field